Sep 19, 09:08
AnnouncementsBrooks Laboratories: Updates on outcome of AGM
67% of moneycontrol users recommend buying Brooks Labs.
What's your call on Brooks Labs today?
Read 5 investor views
|Company Name||Last Price||%
|Dr Reddys Labs||3218.40||0.96||3240.00||2420.00||54,830.54|
|Mar' 14||Dec' 13||Sep' 13||Jun' 13|
|No Mutual Funds Holding the share|
Vaibhav Global Recommended on Jun 11th 2014
Recommended price 675.00 | Peak from reco 975.00 44.44%
What are Multi baggers?
Our experts panel will help you to get you those life-changing stocks, tomorrow's bluechips today.
Brooks Labs is in the Pharmaceuticals sector. The current market capitalisation stands at Rs 67.09 crore.The company has reported a standalone sales of Rs 16.46 crore and a Net Profit of Rs 1.54 crore for the quarter ended Jun 2014.
The company management includes Atul Ranchal - Chairman, Rajesh Mahajan - Managing Director, D S Maity - CEO cum Technical Director, Rajnish Kumar Bedi - Director, Bhaskar Sharma - Director, Deepak Mahajan - Director.
It is listed on the BSE with a BSE Code of 533543 and the NSE with an NSE Code of BROOKS.
Its Registered office is at Village Kishanpura, Nalagarh Road,,Baddi Solan District,Himachal Pradesh - 174101.
Their Registrars are Link Intime India Pvt. Ltd.